Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Acute Med ; 21(2): 115-116, 2022.
Article in English | MEDLINE | ID: mdl-35681187

ABSTRACT

Antimicrobial associated encephalopathy (AAE) is a well-documented, though under recognised, adverse event associated with antimicrobial use. Clinical manifestations of AAE are varied, ranging from myoclonus and seizure to an encephalopathy with cerebellar signs. The phenotypic presentation of the encephalopathy syndrome is, in general, governed by the antimicrobial in question. Given its apparent rarity in everyday clinical practice, awareness of AAE is crucial for physicians. We describe a reversible encephalopathy characterised by confusion, myoclonus and stupor in a 76 year old gentleman on antimicrobial therapy for a peri-rectal abscess.


Subject(s)
Brain Diseases , Delirium , Myoclonus , Aged , Anti-Bacterial Agents/adverse effects , Brain Diseases/chemically induced , Brain Diseases/diagnosis , Brain Diseases/drug therapy , Delirium/chemically induced , Delirium/diagnosis , Humans , Male , Myoclonus/chemically induced , Myoclonus/drug therapy
2.
Ir Med J ; 114(7): 406, 2021 Aug 19.
Article in English | MEDLINE | ID: mdl-34520641

ABSTRACT

Aim Knowledge of latent tuberculosis infection (LTBI) screening and treatment practices are lacking in Ireland, where LTBI is not programmatically surveyed or managed. The aim of this research was to describe current clinical practice when screening and treating patients for LTBI in a tertiary referral centre in Ireland. Methods A 17-question survey relating to LTBI screening and management practices with both open-ended questions and close ended multiple-choice questions was created using SurveyMonkey. The survey target sample was healthcare workers in the tertiary centre who direct LTBI screening and treatment for patients at risk of TB disease in their respective departments. Results The response rate to the survey was 45% (21/47). Seventy-one percent (15/21) of those surveyed responded to the question "What barriers exist to screening patients for latent TB in your clinical practice?". Fifty-three percent (8/15) said that they found it difficult to access LTBI testing and 27% (4/15) cited accessing the interferon-gamma release assay (IGRA) result as a barrier. Forty-three percent (9/21) responded that there was not a clear referral pathway for patients that they would like specialist input on when diagnosing and managing patients with LTBI. Conclusion Access to LTBI testing, LTBI test results, TB specialist services and the use of rifamycin-based regimens should be improved in this tertiary centre. Consideration should be given to developing a national LTBI education programme for healthcare professionals and updating national LTBI treatment guidelines.


Subject(s)
Latent Tuberculosis , Humans , Interferon-gamma Release Tests , Latent Tuberculosis/diagnosis , Latent Tuberculosis/drug therapy , Latent Tuberculosis/epidemiology , Mass Screening , Surveys and Questionnaires , Tertiary Care Centers
5.
Cad. psicol. soc. trab ; 23(2): 218-235, jul.-dez. 2020.
Article in Portuguese | LILACS, Index Psychology - journals | ID: biblio-1249485

ABSTRACT

Este artigo promove um debate que orbita em torno de conceitos, tais como: risco e sofrimento; subjetividade e experiência; cotidiano e memória; vulnerabilidade e precarização. Buscamos compreender as vivências em ambiente de trabalho de enfermeiros e enfermeiras que atuam desde o início da pandemia de Covid-19 (Coronavirus Disease 2019) em dois hospitais públicos de Goiânia, referências no atendimento a indivíduos vitimados pela doença em questão. Destacamos que a realização das entrevistas teve como pano de fundo um contexto de aprofundamento da precarização e da flexibilização das condições e relações de trabalho desses profissionais, associadas ao vertiginoso aumento do número de casos e óbitos entre esses. Com base na história oral temática, constatamos que esses profissionais - embora essenciais no enfrentamento à pandemia - se encontram atualmente ainda mais vulnerabilizados, individual e coletivamente. Ainda que homens e mulheres nessa categoria de trabalhadores experimentem de forma muito diferente o sofrimento e o adoecimento em seus respectivos cotidianos laborais. Particularmente, em função das desigualdades de gênero no mercado de trabalho.


This article discusses concepts such as: risk and suffering, subjectivity and experience; everyday life and memory; vulnerability and precariousness. We analyze the work environment experiences of nurses working since the beginning of the Covid-19 pandemic in two public hospitals in Goiânia, reference hospitals in the care of individuals afflicted by the pathogen in question. The interviews were conducted against a background of deepening in the precariousness and flexibility of working conditions and relationships of these professionals, associated with the vertiginous increase in the number of cases and deaths among them. Based on thematic oral history, we found that these professionals - although essential in facing the pandemic - are currently even more vulnerable individually and collectively, and that men and women of this field experience suffering and illness differently in their respective daily work.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Risk , Psychological Distress , COVID-19 , Nurses/psychology , Employment
9.
Ir Med J ; 113(7): 123, 2020 Jul 30.
Article in English | MEDLINE | ID: mdl-35575598

ABSTRACT

Aim Outpatient parenteral antimicrobial therapy (OPAT) is an option in patients who require parenteral antimicrobial administration and are clinically well enough for hospital discharge. This is an update of the Irish National OPAT guidelines which were last reviewed in 2011. Methods The guideline was devised through a collaborative process with the national OPAT Working Group and a review of the literature. It is intended for clinicians who prescribe any intravenous (IV) antimicrobials outside of the inpatient setting in the Republic of Ireland. Results Patient care while on OPAT should be provided by a designated OPAT service, with clear managerial and clinical governance lines of responsibility. It should be conducted using a team approach with a clinical lead on each site either as an infection specialist, or a general medical physician with infection specialist input and an OPAT nurse. An antimicrobial pharmacist is also desirable. Several factors must be considered when assessing patient's suitability for OPAT including exclusion criteria, infection-specific factors, and patient specific factors such as physical, social and logistic criteria. Conclusion This updated guideline advocates a more individualised OPAT approach, with the recognition that specific antimicrobials and/or specific delivery models may be more appropriate for certain patient groups. Full guidelines are available through www.opat.ie.

10.
Article in English | MEDLINE | ID: mdl-31528337

ABSTRACT

Background: Qualitative work has described the differences in prescribing practice across medical and surgical specialties. This study aimed to understand if specialty impacts quantitative measures of prescribing practice. Methods: We prospectively analysed the antibiotic prescribing across general medical and surgical teams for acutely admitted patients. Over a 12-month period (June 2016 - May 2017) 659 patients (362 medical, 297 surgical) were followed for the duration of their hospital stay. Antibiotic prescribing across these cohorts was assessed using Chi-squared or Wilcoxon rank-sum, depending on normality of data. The t-test was used to compare age and length of stay. A logistic regression model was used to predict escalation of antibiotic therapy. Results: Surgical patients were younger (p < 0.001) with lower Charlson Comorbidity Index scores (p < 0.001). Antibiotics were prescribed for 45% (162/362) medical and 55% (164/297) surgical patients. Microbiological results were available for 26% (42/164) medical and 29% (48/162) surgical patients, of which 55% (23/42) and 48% (23/48) were positive respectively. There was no difference in the spectrum of antibiotics prescribed between surgery and medicine (p = 0.507). In surgery antibiotics were 1) prescribed more frequently (p = 0.001); 2) for longer (p = 0.016); 3) more likely to be escalated (p = 0.004); 4) less likely to be compliant with local policy (p < 0.001) than medicine. Conclusions: Across both specialties, microbiology investigation results are not adequately used to diagnose infections and optimise their management. There is significant variation in antibiotic decision-making (including escalation patterns) between general surgical and medical teams. Antibiotic stewardship interventions targeting surgical specialties need to go beyond surgical prophylaxis. It is critical to focus on of review the patients initiated on therapeutic antibiotics in surgical specialties to ensure that escalation and continuation of therapy is justified.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antimicrobial Stewardship/methods , Drug Prescriptions/statistics & numerical data , Clinical Decision-Making , Humans , Logistic Models , Practice Patterns, Physicians' , Prospective Studies , Specialties, Surgical
11.
J Antimicrob Chemother ; 73(4): 835-843, 2018 04 01.
Article in English | MEDLINE | ID: mdl-29211877

ABSTRACT

Sub-optimal exposure to antimicrobial therapy is associated with poor patient outcomes and the development of antimicrobial resistance. Mechanisms for optimizing the concentration of a drug within the individual patient are under development. However, several barriers remain in realizing true individualization of therapy. These include problems with plasma drug sampling, availability of appropriate assays, and current mechanisms for dose adjustment. Biosensor technology offers a means of providing real-time monitoring of antimicrobials in a minimally invasive fashion. We report the potential for using microneedle biosensor technology as part of closed-loop control systems for the optimization of antimicrobial therapy in individual patients.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Monitoring/methods , Drug Therapy/methods , Drug Utilization/standards , Precision Medicine/methods , Biosensing Techniques/methods , Humans
12.
Ir Med J ; 104(7): 208-11, 2011.
Article in English | MEDLINE | ID: mdl-21957688

ABSTRACT

Patients with inflammatory arthritis are at increased risk of vaccine preventable infections. This risk is increased by immunomodulatory therapies. Vaccination for influenza and pneumococcal disease reduces the risk. Severe cases of varicella infection have occurred in patients on biologic therapies. We sought to identify vaccination rates for commonly acquired infections and to ascertain varicella immune status in patients with inflammatory arthritis. 100 patients with inflammatory arthritis were administered a standardised questionnaire. Data collected included age, diagnosis, vaccination history, history of varicella, treatment and the presence of other indications for vaccination. 58 patients (58%) had not received the influenza vaccine in the past year. Only 19 patients (19%) had ever received pneumococcal vaccine. Anti TNF use did not predict vaccination (p = .46). An increasing number of co morbid conditions predicted both pneumococcal (p < 0.003) and influenza vaccine (p < 0.03) administration. Nineteen patients (19%) gave no history of varicella infection, none having had varicella titres checked pre treatment. Immunisation rates in patients with inflammatory arthritis on immunosuppressive therapies are low. Immunisation schedules should be available for each patient during rheumatology and general practice consultations.


Subject(s)
Arthritis, Rheumatoid/immunology , Chickenpox/immunology , Influenza Vaccines/administration & dosage , Influenza, Human/prevention & control , Pneumococcal Infections/prevention & control , Pneumococcal Vaccines/administration & dosage , Adolescent , Adult , Aged , Aged, 80 and over , Comorbidity , Female , Humans , Influenza, Human/immunology , Ireland , Male , Middle Aged , Pneumococcal Infections/immunology , Surveys and Questionnaires
13.
Biomaterials ; 21(6): 563-9, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10701457

ABSTRACT

The influence of fluorite content of the glass on the formation and properties of glass polyalkenoate cements was investigated. A series of glass powders based on 1.5SiO2 x 0.5P2O5 x Al2O3 x CaO x XCaF2 were synthesised. The glass transition temperature of the glass fell with increasing fluorite content. Setting and working times of the cement pastes decreased with increasing fluorite content of the glass. Compressive strength and un-notched fracture strength increased with increasing fluorite content of the glass. Fracture toughness and toughness of the cements were relatively insensitive to fluorite content.


Subject(s)
Calcium Fluoride/chemistry , Glass Ionomer Cements/chemistry , Glass/chemistry , Compressive Strength , Hardness , Materials Testing , Powders , Temperature
14.
Biomaterials ; 19(6): 495-502, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9645555

ABSTRACT

The influence of substituting sodium for calcium on the properties of glass polyalkenoate cements was investigated. Two series of glass compositions based on PSiO2 x QAl2O3 x 0.75P2O5 x (1 - Z)CaO x XCaF2ZNa2O were studied. The fluorine content was fixed at X = 0.50 and 0.75 and the sodium content varied by altering Z. The glass polyalkenoate cements formed from these glasses were characterized using a linear elastic fracture mechanics (LEFM) approach. In addition, compressive strengths of the cements were determined. The properties of the cements based on the high fluorine content glasses (X = 0.75) were relatively insensitive to sodium content. The Young's modulus, un-notched fracture strength and fracture toughness of the cements produced with the lower fluorine content glasses (X = 0.5) reduced with sodium content, which was consistent with sodium acting to disrupt ionic cross-linking in the polyacrylate matrix. The compressive strength was not as dependent on sodium content as the LEFM parameters.


Subject(s)
Biocompatible Materials/chemistry , Glass Ionomer Cements/chemistry , Sodium/chemistry , Cations/chemistry , Chemical Phenomena , Chemistry, Physical , Fluorine/chemistry , Materials Testing , Mechanics
SELECTION OF CITATIONS
SEARCH DETAIL
...